Skip to main content
Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Fatigue Shifts and Scatters Heart Rate Variability in Elite Endurance Athletes

  • Laurent Schmitt ,

    Affiliation National School of Mountain Sports/National Ski-Nordic Centre, Premanon, Les Rousses, France

  • Jacques Regnard,

    Affiliation University of Franche-Comte, Research unit EA3920, “Prognostic markers and control factors in cardiovascular pathologies” and Physiology Department, University Hospital of Besançon, Besançon, France

  • Maxime Desmarets,

    Affiliation Clinical Research Methods Center, University Hospital of Besançon, Besançon, France

  • Fréderic Mauny,

    Affiliations Clinical Research Methods Center, University Hospital of Besançon, Besançon, France, University of Franche-Comte, Research unit UMR 6249 “Chrono-environment”, University Hospital of Besançon, Besançon, France

  • Laurent Mourot,

    Affiliation University of Franche-Comte, Research unit EA4660 “Culture Sport Health Society and Exercise Performance Health Innovation platform”, UPFR des Sports 31 chemin de l’Epitaphe, Besançon, France

  • Jean-Pierre Fouillot,

    Affiliation University of Paris 13, Research unit EA2363, ARPE, 74 rue Marcel Cachin, Bobigny, France

  • Nicolas Coulmy,

    Affiliation French Ski Federation, 50 rue des Marquisats, BP 2451, Annecy, France

  • Grégoire Millet

    Affiliation Institute of Sport Sciences, Department of Physiology, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland



This longitudinal study aimed at comparing heart rate variability (HRV) in elite athletes identified either in ‘fatigue’ or in ‘no-fatigue’ state in ‘real life’ conditions.


57 elite Nordic-skiers were surveyed over 4 years. R-R intervals were recorded supine (SU) and standing (ST). A fatigue state was quoted with a validated questionnaire. A multilevel linear regression model was used to analyze relationships between heart rate (HR) and HRV descriptors [total spectral power (TP), power in low (LF) and high frequency (HF) ranges expressed in ms2 and normalized units (nu)] and the status without and with fatigue. The variables not distributed normally were transformed by taking their common logarithm (log10).


172 trials were identified as in a ‘fatigue’ and 891 as in ‘no-fatigue’ state. All supine HR and HRV parameters (Beta±SE) were significantly different (P<0.0001) between ‘fatigue’ and ‘no-fatigue’: HRSU (+6.27±0.61 bpm), logTPSU (−0.36±0.04), logLFSU (−0.27±0.04), logHFSU (−0.46±0.05), logLF/HFSU (+0.19±0.03), HFSU(nu) (−9.55±1.33). Differences were also significant (P<0.0001) in standing: HRST (+8.83±0.89), logTPST (−0.28±0.03), logLFST (−0.29±0.03), logHFST (−0.32±0.04). Also, intra-individual variance of HRV parameters was larger (P<0.05) in the ‘fatigue’ state (logTPSU: 0.26 vs. 0.07, logLFSU: 0.28 vs. 0.11, logHFSU: 0.32 vs. 0.08, logTPST: 0.13 vs. 0.07, logLFST: 0.16 vs. 0.07, logHFST: 0.25 vs. 0.14).


HRV was significantly lower in 'fatigue' vs. 'no-fatigue' but accompanied with larger intra-individual variance of HRV parameters in 'fatigue'. The broader intra-individual variance of HRV parameters might encompass different changes from no-fatigue state, possibly reflecting different fatigue-induced alterations of HRV pattern.


In elite sport, athletes training loads and recovery periods are managed to transitory disturb homeostasis and to subsequently reap a higher performance level [1]. This management has to avoid fatigue accumulation, which could abrade performance. As described by Meeusen et al. [2], the development of fatigue follows a continuum process ranging from voluntary and controlled fatigue necessary for performance progression and requesting few hours or few days of recovery, named functional over-reaching (FOR) [3], [4], until involuntary and uncontrolled fatigue requesting weeks or even months of recovery, named non functional OR (NFOR) [2] or overtraining (OT) [5] when it has become a “prolonged maladaptation”. In case of NFOR or OT, the increased recovery time results in a lack of training, a decrease of the physical capacities and finally an impaired performance [2]. Such an extreme fatigue can even cause the end of an athlete’s career.

The difficulty to distinguish FOR and specially NFOR from OT is well recognized [2], [6]. This is partially due to the fact that the multiple clinical signs of fatigue stem not only from training overload with inadequate rest but also from various inputs as psychological stress, nutritional imbalance, mild inflammatory disorders, etc… Several tools have been proposed to assess the fatigue level in daily routine. Among them, analysis of heart rate variability (HRV) provides an indirect evaluation of the heart control by the autonomic nervous system (ANS), and was highlighted as a promising tool [2]. Several studies attempted to unveil links between the training loads, the state of fatigue and the changes in ANS activity as reflected by HRV [7][14]. Unfortunately, the results of these studies were equivocal. In a case study of one overtrained cross-country skier, Hedelin et al. [11] reported reduced competition performance and lowered profile of mood states, along a decrease in absolute low frequency power (LF) while absolute HF power remained high. Conversely, Uusitalo et al. [12] showed that OT was associated with HRV descriptors in which HF power was decreased in nine female endurance athletes undergoing heavy training over a 6–9 week period. And Hedelin et al. [14] reported unchanged HRV values in nine overreached canoeists after increasing training load by 50% over a 6-day training camp, despite concomitant decreases in maximal blood lactate concentration, running time to fatigue, maximal and submaximal heart rate, as well as maximal oxygen uptake (O2max).

These discrepant results might be related to several conditions. The former studies were conducted on quite short follow-up periods (few weeks or months in most cases) and involved a limited number of athletes (1 to ∼10–15). The protocols used were sometimes designed to artificially overload the athletes, without substantial evidence that a fatigue state had been induced. Another point of interest for the monitoring of athletes might be the assessment of HRV dispersion as shown recently in Plews et al. [15]. Therefore, if the different fatigue patterns quoted above were to be recognized according to different shifts in HRV parameters, then HRV parameters dispersion could reach broader ranges in ‘fatigue’ than in ‘no-fatigue’ states.

The present longitudinal study was conducted with records taken in ‘real life’ conditions. It aimed firstly at comparing HRV differences in elite Nordic skiers who were recognized either in a ‘fatigue’ or in a ‘no-fatigue’ state, independently of HRV recording, and secondly at measuring the fluctuation span of the HRV parameters in these two states. The hypotheses tested were firstly that HRV parameters of the athletes would be significantly different in the ‘fatigue’ and in the ‘no-fatigue’ states and, secondly that the dispersion of individual HRV parameters would be larger in the ‘fatigue’ state than in ‘no-fatigue’ condition.


Ethic Statement

The study submitted here was part of a larger project designed as “Hypoxic training in high level endurance athletes: evaluation of effects on the performance, research of individual responses, evaluation of potential risks for the health”. The whole project was approved by the Necker Hospital Ethic Committee (Paris, France). All the subjects provided written, voluntary, informed consent.

Experimental Design

French elite Nordic skiers were involved in a 4-year follow-up. No ‘artificial’ change was applied to their training program. The fatigue state of the athletes was assessed by using the questionnaire designed and validated by the consensus group on overtraining of the French Society of Sports Medicine (QSFMS) (e.g. Table S1) [16][18].

The experiments were performed at the French Nordic-ski centre of Prémanon, France, between 2004 and 2008, by the same investigator, head physiologist of the Nordic ski teams, in French national teams of three disciplines: biathlon, Nordic-combined and cross-country skiing. HRV testing was part of the follow-up of the athletes during their yearly preparation for World cups and World championships and also during their Olympic preparation in 2006. During the 4-year study, the recordings of HRV were not prospectively scheduled, but the athletes were requested to regularly perform the HRV test, during every period of the training plan that can be described as: the general training period takes place in May and June and embeds base aerobic and strength training sessions; the specific training period follows with base aerobic, maximal aerobic and strength training sessions in July, August and September; the precompetitive period occurs in October and November and holds base aerobic, maximal aerobic and strength training sessions and altitude training camps. The competition period encompasses December to March, and April is the recovery period.


The subjects were 57 (27 men, 30 women) members of the French national teams of the Nordic ski disciplines and included 8 medallists of the Olympics Games, the World championships or the World cup. Inclusion criteria were as follows: elite athlete member of the French national teams from 2004–2005 to 2007–2008 training seasons with at least one declared fatigue state. So, only athletes with both ‘fatigue’ and ‘no-fatigue’ states were included retrospectively.

Exclusion criteria were to be injured or sick for longer than 5 consecutive days or to stop the international sporting career.

All these subjects had a maximum oxygen consumption (O2max) measurement at the entrance of the period of the study, all measured during an incremental treadmill test at the altitude of 1200 m as described earlier [19].

HRV Tests

The tests were always performed in the same conditions. The subjects arrived at the national French training centre at 8h30 in the morning before the first training session of the day. All the athletes of one team completed together the HRV tests in the medical laboratory under supervision of the same investigator. No heavy training session took place during the two days preceding the HRV tests. During the competition period, the tests were performed on Wednesday morning, i.e. after two full days of easy aerobic training following the last competition run which usually take place Saturday and/or Sunday.

After a 15-min rest, the test began with 8 min supine (SU) followed by 7 min standing (ST). HRV analyses were performed on RR intervals recorded between the 3rd and 8th min supine, and between the 9th and 14th min standing. Measurement of the interval duration between two R waves of the cardiac electrical activity was performed with a HR monitor (T6, Suunto®, Vantaa, Finland). HRV assessment from these RR intervals has been validated against ECG measurements [20]. Each data file was visually inspected for artifacts, which were manually corrected. Then the spectral power was calculated with Fast Fourier Transform (FFT) according to the specific software (Nevrokard® HRV, Medistar, Ljubljana, Slovenia). Recording periods of 256 s were analysed, each yielding 512 data points after re-sampling at the 2 Hz frequency. The Hanning windowing function was applied and the Goertz algorithm was used for calculation. The power spectral density was measured by frequency bands in ms2.Hz−1 and the spectral power was expressed in ms2 [21] : High frequency (HF) power band (0.15 to 0.40 Hz) reflects the parasympathetic influence and is related to the respiratory sinus arrhythmia [22]; Low frequency (LF) power band (0.04 to 0.15 Hz) is also driven by parasympathetic tone, and is presently considered as carrying vagal resonances to either changes in vasomotor tone (often sympathetic) or in central modulation of sympathetic tone [23]; the spectral power in this frequency band has been found related to arterial blood pressure [22], [24] and to baroreflex activity [25].

During the tests, the investigator surveyed visually the breathing frequency and timed it with a frequency-meter, because a very low rate, under 9 cycles per min, could shift frequencies lower than 0.15 Hz and decrease the HF band or increase the LF band [26].

Both in supine (SU) and in standing (ST) positions, LF and HF were calculated in absolute spectral power units (ms2) and in normalized units (nu) with LF(nu) = LF/(LF+HF)×100 and HF(nu) = HF/(HF+LF)×100. The total spectral power (TP) was calculated by adding LF and HF. The LF/HF ratio was also calculated as an indicator of sympathetic over parasympathetic balance [21].

Definition of the State of Fatigue

The states of fatigue were identified according to the scoring at the QSFMS (Table S1), which was fulfilled after the RR interval recording procedure. This questionnaire is used routinely in French national teams in various sports (rugby, swimming, Nordic-ski, triathlon…). It has been built up by the consensus group on overtraining of the French Society of Sports Medicine, a large panel of scientists and sport physicians. This standardized description of the psychological/behavioural state takes into account different contributions to fatigue linked to physical exercising. A score calculated from the answers to the QSFMS quantifies the clinical symptoms of overtraining. The state of fatigue was registered when the score exceeded 20 negative items out of 54 [16], [17]. This score was shown to correlate with indications of muscular damage (creatine kinase, myosin) and some hematological variables (blood viscosity, hematocrit, plasma viscosity, ferritin) [16].

Statistical Analysis

The ‘Fatigue’ variable was dichotomized according to the threshold of 20 items with a negative answer. In each recording position (SU and ST) of RR intervals the following variables describing heart rate variability (HRV) were quantified. HRSU, HRST, LFSU(nu), HFSU(nu), LFST(nu), HFST(nu) were assumed to be distributed normally. The remaining variables were transformed by taking their common logarithm (log10).

The relationships between the HRV parameters and the state of ‘fatigue’/‘no-fatigue’ variable were analyzed using a multilevel linear regression model with a complex variance structure. In this model, level 1 was the rank of the measure and level 2 the subject. The rank (for one given subject, each successive rank labelled a recording date) of the measure was used as an orthogonal polynomial in order to account for repeated measurements. Each HRV variable was first analyzed in a univariate model. Gender and age of the subjects were introduced in the statistical model. A random parameter was finally introduced at level 1 in order to control for heteroscedasticity of the HRV parameters. This random parameter allowed assessing differences in HRV power dispersion between ‘fatigue’ and ‘no-fatigue’ states in each subject. Normal distribution of the residuals was checked on final models. Significance threshold was set to 0.05. Analyses were performed using MLwiN V2.20 [27]. These models allowed analyzing unbalanced data, as the number of recordings for each subject.


The characteristics of the subjects as they entered the study are shown in Table 1. The values of O2max were consistent with the elite level of the subjects.

Table 1. Anthropometric characteristics and O2max of the subjects at the time of their inclusion in the study.


The distribution of the QSFMS scores is displayed in Figure 1. The average score of the 1063 tests performed was 8.84 (Standard deviation, SD = 8.94). 172 tests had a score higher than 20 indicating a ‘fatigue’ state, which amounted to 16.2% of all the tests performed. Figure 1 also displays the distribution of the number of tests performed, and for every athlete indicates the number of ‘fatigue’ and ‘no-fatigue’ states diagnosed with the QSFMS.

Figure 1. Number of HRV tests recorded in ‘No-fatigue’ and ‘Fatigue’ state in each subject, and overall distribution of the QSFMS scores.

In each subject’s column the HRV recordings obtained when the QSFMS had a score under the 20-item threshold are in white, and those recorded during a scored state of fatigue are in black.

HRV Analysis

During the tests, the breathing frequencies (BF) were recorded and no breath holding period was observed.

Supine and standing BF data in ‘fatigue’ and ‘no-fatigue’ states are displayed in Table 2.

Table 2. QSFMS, Breath Frequency (BF), Heart Rate (HR) and parameters of heart rate variability (HRV): distribution of values across the ‘no-fatigue’ and ‘fatigue’ states.

Table 2 and Figure 2 describe the distribution of values of HRV parameters recorded in all the subjects both the ‘no-fatigue’ and ‘fatigue’ states. Table 3 displays the results of the multilevel linear regression models with the intra-subject variances.

Figure 2. Distribution of values in heart rate and HRV parameters according to ‘fatigue’ and ‘no-fatigue’ states in supine (A) and standing (B) positions.

The box and whiskers display values of all recordings for all the subjects. Box is defined by the first and third quartiles. The thick line stands for the median value. The tenth and ninetieth of values are marked by the “wisker” bars, and the circles stand for the lowest and highest values. The highest values are out of scale and the number is written at the right end of the bar close to the circle that should stand out of scale. The dotted dark line symbolizes a discontinued scale. The ‘fatigue’ states are in grey and the ‘no-fatigue’ states are in white. ‘no-Fatigue’ state n = 891, ‘fatigue’ state n = 172. SU = supine position; ST = standing position; HR = heart rate (beat per minute); TP = total spectral power (ms2); LF = spectral power in the low frequency band (ms2); HF = spectral power in the high frequency band (ms2). Right figure is the highest value of the file. † Analysis was conducted on Log transformed data. ### for p<0.001 in differences between ‘fatigue’ and no-fatigue state using multilevel models. The scaling was chosen for a clear display of figures span of each parameter. Therefore scales are different between parameters and between supine and standing positions. It has to be noticed that the distribution of values displayed in this figure are computed from all the recordings of every subject cannot be directly compared with the intra-individual variances assessed by the multi-level analysis (Table 3).

Table 3. HRV parameters across ‘fatigue’ and ‘no-fatigue’ state: multilevel linear modelling.

In supine position, the HR values were on average 6.27 bpm higher in recordings performed in the ‘fatigue’ state than when there was ‘no-fatigue’ (P<0.0001). Conversely, the HF power (nu) was on average 9.55 lower in the ‘fatigue’ than the ‘no-fatigue’ (P<0.0001). Thus, in ‘fatigue’ state, logTPSU, logLFSU, logHFSU, and HFSU(nu) were significantly lower than in ‘no-fatigue’ state (all P<0.0001). Conversely, logLF/HFSU was larger in ‘fatigue’ state (P<0.0001). In standing position, HRST was higher and logTPST, logLFST, logHFST were lower with fatigue than without (P<0.0001).

The intra-subject HR variances were larger in ‘fatigue’ than ‘no-fatigue’ state in the supine position (respectively: 53.09 vs 31.86; P<0.0006) and in the standing position (respectively 115.37 vs 71.44; P<0.001). Intra-subject variance was also larger in fatigue state for logTPSU, logLFSU, log HFSU, logTPST, logLFST, logHFST (P<0.0001). These statistically significant results are thus not reflected in the group description displayed in Figure 2.

The model did not reveal any difference linked to gender or age of the subjects.

Figure 3 displays examples of HRV analysis monitoring from individual measurements in ‘fatigue’ and ‘no-fatigue’ states in supine and standing positions.

Figure 3. Cases examples of HRV analysis monitoring from individual measurements in ‘fatigue’ and ‘no-fatigue’ states in supine (A) and standing (B) positions.

For three subjects in supine (A) and three other in standing (B) positions, monitoring of total spectral power (TP) by adding low and high frequencies in absolute units (ms2) and heart rate (HR) (bpm) during the same surveyed year. ‘no-fatigue’ points are in white and “fatigue’ points in black.


This study surveyed elite endurance athletes over a multi-year period without any ‘artificial’ (e.g. study-related) change of their training regimen. It led to two main results. Firstly, as hypothesized, most of the HRV parameters were different in ‘fatigue’ vs. ‘no-fatigue’ states. These differences were observed both in supine (HR, LF/HF and LFnu increased; LF, HF, TP, HFnu decreased in ‘fatigue’) and in standing (HR increased; LF, HF and TP decreased in ‘fatigue’) positions. Secondly, the intrasubject variance of HR, LF, HF and TP was significantly larger in ‘fatigue’ than in ‘no-fatigue’ state. This suggests that different fatigue-shifted HRV patterns coexist in the ‘fatigue’ state.

Most studies investigating the relationships between fatigue (e.g. during states labelled as OR (FOR or NFOR) or OT [2]) and HRV embedded methodological features that limit the impact of their findings. Indeed, most studies enrolled few athletes (1 to 10–15; e.g.; Hedelin et al. [11], [14]; Uusitalo et al. [12]). Considering the high inter-individual variation in the response to training and fatigue, the small subject number largely increases the risk of statistical errors. Also, in some studies the usual training regimen of the subjects was modified by artificially introducing an overload period [8], [12], which makes it difficult to ascertain that a true state of fatigue is achieved. Moreover, some of the previously published studies did not clearly describe the criteria used to separate the ‘fatigue’ and ‘no-fatigue’ states [11], [28]. Finally, the fact that physiological data recorded or investigated in sub-elite [28] or well-trained subjects cannot be translated to elite level is also of importance [29].

While HRV recording tests were not performed as many times in every athlete, we used an appropriate statistical approach. The statistical multilevel model was not affected by the non balanced number of recordings in subjects [30]. In addition the model coped with heteroscedasticity, i.e. the non homogenous variance of HRV parameters across the two states of the ‘fatigue’ independent variable. The conditions and procedure of data recording were also greatly standardized, i.e. same location (medical laboratory); same timing in the day and the week; same recording device; same investigator; routinely implemented HRV recordings. This likely contributed to reduce misleading causes of variance in results.

HRV values were obtained before the subject completed the QSFMS questionnaire (Table S1). The questionnaire data were analyzed afterward and blindly from the HR recording. Thus quoting a ‘fatigue’ state was done independently of HRV analysis. In this study, quoting a ‘fatigue’ state according to the threshold of 20 negative items out of 54 was the only criterion for statistical comparison of HRV data in a model that takes into account potential intra-subject pairing of data between ‘fatigue’ and ‘no-fatigue’ states.

In a comprehensive review on prevention, diagnosis and treatment of the overtraining syndrome, Meeusen et al. [2] highlighted the importance of the diagnosis and follow-up of the fatigue changes in elite sport. The authors reported the pros and cons of different methods currently used; e.g. analysis of the hormonal status (testosterone/cortisol ratio, ACTH/cortisol ratio, growth hormone, insulin-like-growth-factor-I), of the performance level, of the psychological and mood state (Profile of Mood State, POMS; Recovery-Stress Questionnaire, RestQ-Sport or the Daily Analysis of Life demands of Athletes, DALDA), of the immune function, and finally of the HRV. It is largely recognized that a single biological marker is only very seldom determinant in diagnosing a fatigue state. When this occurs, several other symptoms -and other biological signs- are most often gathered to highlight a severe fatigue state. Such a recognition happens often late in the course of the athlete’s follow-up. Obtaining biological values requires blood sampling and/or urine sampling, is invasive and costly, and hence cannot be repeated frequently, i.e., as frequently as requested in monitoring elite athletes in whom extended impairment of function should be avoided. HRV recording is just the opposite on several points, and therefore it could be easily used in daily routine [2]. The idea of fatigue encompasses more than overtraining. Fatigue likely comprises different kinds of impairments not only triggered by the imbalance of training load and recovery, but also by e.g. infectious episode, impaired sleep (which can be a symptom of fatigue) or emotional/affective insult… [2]. All these conditions can lead to some physiological imbalance likely to involve some shift in autonomic settings, and finally some cardiac HRV change.

Using the 20 items threshold of the QFSMS questionnaire (Table S1) to separate fatigue and no-fatigue records (Figure 1), the multilevel linear regression model used in this study led to significant differences between the ‘fatigue’ and ‘no-fatigue’ states in most HRV descriptors (Table 3). On average HR was higher and HRV was lower during fatigue than in no-fatigue state both supine and standing (Table 2 and Figure 2). Less of autonomic inputs or resonances to physiological signals imply less accurate autonomic controls. Hence some loss of efficiency is likely in metabolic and physiological functions, which are instrumental to sharp sport performance. The lowering of HR autonomic control would thus appear as an easily discernible cue of more complex and widely spread impairments in fatigue states. All the frequency band descriptors were lowered in fatigue state. In supine position, the power decrease was lesser in LF than HF, leading to a higher LF/HF ratio and suggesting a less parasympathetic control on HR. The changes in LFnu and HFnu also displayed this pattern. The simultaneous decrease of total spectral power and the larger contribution of LF variability were thus in line with previous reports in fatigue after competition [31] overreaching [32], [33] or overtraining states [8], [10], [12]. In the standing position, the ‘fatigue’ state was associated on average with decreased TP, LF and HF powers and increased HR; but the values of LF/HF ratio and LF(nu) were not significantly different from the ‘no-fatigue’ state. The methodology used in this study does not allow searching for any particular state or cause of fatigue.

The increase in heart rate would be simply explained in a reciprocal activation pattern of autonomic arms [34]. Indeed the higher HR in fatigue state leads to the idea of a decreased vagal influence also possibly associated with an increased sympathetic activation. As all absolute HRV variables (TP, LF and HF spectral powers) are mainly under vagal modulation and are lowered, a lessened vagal modulation of heart activity is most likely when fatigued. The observation of higher LF/HF at supine rest supports the idea that a balanced autonomic control has shifted towards sympathetic predominance. A co-activation of vagal and sympathetic outflows might bring opposite changes in HR and in the relationship between the dynamics of HR and LF/HF ratio [34], [35]. Such a co-activation of autonomic arms is thus very unlikely in the present results. A further detailed recognition of different patterns of changes in spectral powers is difficult, and the assessment of potential linkages between such successive patterns requires models of data analysis that are beyond the scope of this study.

Significant differences in supine LF/HF and normalized LF and HF between No-Fatigue and Fatigue, but not in standing figures might be questioning. We believe this discrepancy is due to the following points. Firstly, the normalized values depend on the total power of HRV, which is largely lowered in fatigue states, and reduces in turn the scaling of normalized indices. Secondly, LF power holds much of parasympathetic influence. The reduction of HF power in fatigue states thus influences both terms of the ratio LF/HF and narrows its changes. Thirdly, since standing reduces total power and HF power in No-Fatigue state, and this physiological response occurs also during Fatigue states, the statistical assessment of significant further change in LF/HF due to fatigue becomes less likely (as reflected in median and mean figures). In standing position, the LF power likely embeds a larger vascular (e.g. pulse pressure) resonance than in supine position, which accounts for the higher LF/HF ratio in upright position. LF/HF value is more complexly determined than the quite simple ‘gold-standard’ criterium sometimes considered in HRV fatigue studies [23], [25]. We believe also that, although the comparison of standing and supine values is more complex in the fatigue than the ‘No-Fatigue’ state, taking it into account adds insight into HRV changes caused by ‘Fatigue’. Relative variables such as LF/HF ratio and “normalized” power might be useful, but each also presents a “constructed” view of data, easily confounding if not considered in the frame of the primary data.

Beside the overall differences in HRV parameters in ‘fatigue’ vs. ‘no-fatigue’ states, another finding of this study was the broader spanning of intra-subject HRV values in the fatigue state, as depicted by “variance” figures in the statistical model (Table 3). To the best of our knowledge, this has not been reported previously. The dispersion of values of HRV parameters between subjects (e.g. between-subject variance) is known to depend on age, gender, heritability, environmental factors such as noise, temperature, light [21], but the statistical analysis did not reveal any difference linked to gender or age of the subjects in our study. The dispersion of values of HRV parameters between athletes might also depend on the level of practice, the amount and type of physical activity. Such influences have been reported in normal or sedentary population [36][38]. Also, while monitoring the usual training course of such elite athletes, HRV tests are hardly obtained in exactly similar training conditions, particularly as regarding training load. In the present study, methodological precautions were taken to standardize the RR recordings used to HRV analysis. The subjects were homogenous regarding fitness and a several years training level. Also, as already stated, the statistical analysis relied on a model in which each subject was taken as his own reference, and to avoid potential confusion bias adjustment on a particular variable was performed when required. Therefore we believe that the shifts in quantitative repartition of HRV values are meaningful.

In sedentary subjects, Kleiger et al. [39] have reported the substantial variation in HRV values in fourteen normal subjects aged 20 to 55 years. Noritake et al. [40] found a larger diurnal variation in HRV parameters in nineteen healthy subjects than in twenty-nine diabetic patients. Similarly, Plews et al. [15] reported recently a case study of an elite triathlete in whom the day-to-day variation in the square root of the mean sum of the squares differences between R-R intervals (RMSSD), a temporal marker of the parasympathetic influence, was decreased in an OR state. This narrowed fluctuation of HRV when overreached seems conflicting with our results. However, we believe this discrepancy is mainly due to the fact that in the present study the broader span of values of HRV parameters in the ‘fatigue’ state encompasses different patterns of fatigue-induced changes in HRV spectra, which can display different or opposite shifts within the HRV spectrum. The study was not aimed at analyzing day-to-day variability but to highlight the complex content of HRV analysis. By the way, we support the point expressed in the paper by Plews et al. [15] that a decrease in day-to-day fluctuation of HRV parameters over a short period of time might help diagnosing the onset of overreaching. Also, a diversity of types of ‘fatigue’ could explain the higher intra-individual HRV variance when compared to ‘no-fatigue’ state, although each single ‘fatigue’ condition over few days can be stable or tend towards no response with the ‘law of initial values’ described in Plews et al. [15].

Our results may suggest that different and sometimes opposite autonomic regulatory influences could be explained by different degrees or states of fatigue, such as OR or OT [2]. The point of transition between these states is not precisely defined in the literature. This would explain why previous studies have reported equivocal findings, with increases [11], decreases [12] and no change [13], [14] in HRV power during OR or OT states. The greater variance of HRV figures in elite athletes in ‘fatigue’ state could suggest that different fatigue-shifted HRV patterns were simultaneously considered in this study, which is an entangled situation. Assessment of different degrees and sub-categories of fatigue and of the effectiveness of HRV in their recognition in elite athletes, require other kind of statistical models. Finally, the QSFMS questionnaire (Table S1) was validated to highlight a state of fatigue but it is possible that it only allows distinguishing the ‘fatigue’ state from ‘no-fatigue’ state. As far as we know, this questionnaire does not allow to distinguish sub-categories of fatigue.

Limits and Strengths of the Study

As most ‘field’ studies, this retrospective longitudinal study has limits: i) The frequency of records was different between the athletes due to several factors: variable presence in the National centre; competition schedule (different between the Nordic disciplines and between men and women); examinations; illnesses… However, the statistical method was chosen to cope with this non balanced individual number of HRV recordings. ii) The quantification of objective performance is difficult in the Nordic ski disciplines since velocity is largely influenced by the environmental conditions (elevation, quality of snow, weather…). Thus a performance quotation valid enough to enhance the fatigue assessment performed with the QSFMS questionnaire would be difficult to implement. iii) Within the two days preceding HRV recording, the training content was strictly aerobic although it might individually fluctuate in volume, and thus somewhat influence the ensuing HRV values.

However, we believe that this study is unique for several reasons: i) The sample size is unequalled in a study involving elite athletes. ii) The very long period of investigation likely counterbalances some seasonal variations. iii) The reproducibility of HRV recordings and their technical quality were satisfying: same location (medical laboratory); same timing in the day and the week; same device; same investigator; routinely implemented HRV recordings. iv) The assessment of the states of ‘fatigue’ and ‘no-fatigue’ was based on a widely used tool and on an a priori threshold independent of HRV analysis. v) From a practical point of view, we consider the present study established a first step in relevance of frequency-domain HRV analysis for monitoring the fatigue in elite endurance athletes. It is at this stage difficult to speculate how various influences combine to enhance or decrease parasympathetic drive or resonance to sympathetic central or vasomotor control as carried in vagal efference to the heart.


Values of HRV descriptors were significantly lower in ‘fatigue’ than ‘no-fatigue’ states in elite endurance athletes, both in supine and standing positions, over a multi-year period and without any ‘artificial’ change in their training regimen. The main trend by far was a ‘fatigue’-linked lowering of total HRV power as well as in the LF and HF frequencies bands. In addition, the intra-subject variance of values of HRV descriptors was larger in ‘fatigue’ than in ‘no-fatigue’ state. These differences strongly suggest that the ‘fatigue’ state encompassed differently-oriented shifts of HRV pattern, possibly reflecting differently-organized autonomic responses to “fatigue”. Further evaluation is required to assess how a thorough HRV analysis might help to distinguish between hypothetical different fatigue patterns.

Supporting Information

Table S1.

Questionnaire of the French Society of Sport Medicine (QSFMS).



We thank the athletes of the French national Biathlon, Nordic-combined and Cross-country skiing teams and their coaches: for biathlon: Patrice Bailly-Salins, Pascal Etienne, Lionel Laurent; for Nordic-combined: Etienne Gouy, Jérôme Laheurte; for cross-country skiing: Gilles Berthet, Olivier Michaud, Philippe Grand-Clément.

Author Contributions

Conceived and designed the experiments: LS JR MD FM LM JPF NC GM. Performed the experiments: LS JR LM JPF NC GM. Analyzed the data: LS JR MD FM LM JPF GM. Contributed reagents/materials/analysis tools: LS JR MD FM LM JPF NC GM. Wrote the paper: LS JR FM LM JPF GM.


  1. 1. Fiskerstrand A, Seiler KS (2004) Training and performance characteristics among Norwegian international rowers 1970–2001. Scand J Med Sci Sports 14: 303–310.
  2. 2. Meeusen R, Duclos M, Foster C, Fry A, Gleeson M, et al. (2013) Prevention, diagnosis, and treatment of the overtraining syndrome: joint consensus statement of the European College of Sport Science and the American College of Sports Medicine. Med Sci Sports Exerc 45: 186–205.
  3. 3. Jost J, Weiss M, Weicker H (1989) Comparison of sympatho-adrenergic regulation at rest and of the adrenoceptor system in swimmers, long-distance runners, weight lifters, wrestlers and untrained men. European journal of applied physiology and occupational physiology 58: 596–604.
  4. 4. Halson SL, Lancaster GI, Jeukendrup AE, Gleeson M (2003) Immunological responses to overreaching in cyclists. Med Sci Sports Exerc 35: 854–861.
  5. 5. Matos NF, Winsley RJ, Williams CA (2001) Prevalence of nonfunctional overreaching/overtraining in young English athletes. Med Sci Sports Exerc 43: 1287–1294.
  6. 6. Fry R, Lawrence S, Morton A, Schreiner A, Polglazc T, et al. (1993) Monitoring training stress in endurance sports using biological parameters. Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine 3: 6–13.
  7. 7. Lee CM, Wood RH, Welsch MA (2003) Influence of short-term endurance exercise training on heart rate variability. Med Sci Sports Exerc 35: 961–969.
  8. 8. Pichot V, Busso T, Roche F, Garet M, Costes F, et al. (2002) Autonomic adaptations to intensive and overload training periods: a laboratory study. Med Sci Sports Exerc 34: 1660–1666.
  9. 9. Uusitalo AL, Uusitalo AJ, Rusko HK (1998) Endurance training, overtraining and baroreflex sensitivity in female athletes. Clin Physiol 18: 510–520.
  10. 10. Mourot L, Bouhaddi M, Perrey S, Cappelle S, Henriet MT, et al. (2004) Decrease in heart rate variability with overtraining: assessment by the Poincare plot analysis. Clin Physiol Funct Imaging 24: 10–18.
  11. 11. Hedelin R, Wiklund U, Bjerle P, Henriksson-Larsen K (2000) Cardiac autonomic imbalance in an overtrained athlete. Med Sci Sports Exerc 32: 1531–1533.
  12. 12. Uusitalo AL, Uusitalo AJ, Rusko HK (2000) Heart rate and blood pressure variability during heavy training and overtraining in the female athlete. Int J Sports Med 21: 45–53.
  13. 13. Uusitalo AL, Uusitalo AJ, Rusko HK (1998) Exhaustive endurance training for 6–9 weeks did not induce changes in intrinsic heart rate and cardiac autonomic modulation in female athletes. Int J Sports Med 19: 532–540.
  14. 14. Hedelin R, Kentta G, Wiklund U, Bjerle P, Henriksson-Larsen K (2000) Short-term overtraining: effects on performance, circulatory responses, and heart rate variability. Med Sci Sports Exerc 32: 1480–1484.
  15. 15. Plews DJ, Laursen PB, Kilding AE, Buchheit M (2012) Heart rate variability in elite triathletes, is variation in variability the key to effective training? A case comparison. Eur J Appl Physiol.
  16. 16. Benhaddad A, Bouix D, Khaled S, Micallef JP, Mercier J, et al. (1999) Early hemorheologic aspects of overtraining in elite athletes. Clin Hemorheol Microcirc 20: 117–125.
  17. 17. Maso F, Lac G, Filaire E, Michaux O, Robert A (2004) Salivary testosterone and cortisol in rugby players: correlation with psychological overtraining items. Br J Sports Med 38: 260–263.
  18. 18. Varlet-Marie E, Maso F, Lac G, Brun JF (2004) Hemorheological disturbances in the overtraining syndrome. Clin Hemorheol Microcirc 30: 211–218.
  19. 19. Schmitt L, Fouillot JP, Millet GP, Robach P, Nicolet G, et al. (2008) Altitude, heart rate variability and aerobic capacities. Int J Sports Med 29: 300–306.
  20. 20. Weippert M, Kumar M, Kreuzfeld S, Arndt D, Rieger A, et al. (2010) Comparison of three mobile devices for measuring R-R intervals and heart rate variability: Polar S810i, Suunto t6 and an ambulatory ECG system. Eur J Appl Physiol 109: 779–786.
  21. 21. Task-Force (1996) Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93: 1043–1065.
  22. 22. Akselrod S, Gordon D, Ubel FA, Shannon DC, Berger AC, et al. (1981) Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science 213: 220–222.
  23. 23. Reyes Del Paso GA, Langewitz W, Mulder LJ, van Roon A, Duschek S (2013) The utility of low frequency heart rate variability as an index of sympathetic cardiac tone: A review with emphasis on a reanalysis of previous studies. Psychophysiology 50: 477–87.
  24. 24. Pomeranz B, Macaulay RJ, Caudill MA, Kutz I, Adam D, et al. (1985) Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol 248: 151–153.
  25. 25. Goldstein DS, Bentho O, Park MY, Sharabi Y (2011) Low-frequency power of heart rate variability is not a measure of cardiac sympathetic tone but may be a measure of modulation of cardiac autonomic outflows by baroreflexes. Exp Physiol 96: 1255–1261.
  26. 26. Hansson-Sandsten M, Jonsson P (2007) Multiple window correlation analysis of HRV power and respiratory frequency. IEEE Trans Biomed Eng 54: 1770–1779.
  27. 27. Rasbash J, Steele F, Browne WJ, Goldstein H (2011) A User's Guide to MLwiN; Modelling CfM, editor. United Kingdom: University of Bristol.
  28. 28. Baumert M, Brechtel L, Lock J, Hermsdorf M, Wolff R, et al. (2006) Heart rate variability, blood pressure variability, and baroreflex sensitivity in overtrained athletes. Clin J Sport Med 16: 412–417.
  29. 29. Joyner MJ (2011) Into the real world: physiological insights from elite marathoners. Med Sci Sports Exerc 43: 655.
  30. 30. Goldstein H (1995) Multilevel Statistical Models. London.
  31. 31. Gratze G, Rudnicki R, Urban W, Mayer H, Schlogl A, et al. (2005) Hemodynamic and Autonomic Changes Induced by Ironman: Prediction of Competition Time by Blood Pressure Variability. J Appl Physiol 99: 1738–1735.
  32. 32. Pichot V, Roche F, Gaspoz JM, Enjolras F, Antoniadis A, et al. (2000) Relation between heart rate variability and training load in middle-distance runners. Med Sci Sports Exerc 32: 1729–1736.
  33. 33. Iellamo F, Legramante JM, Pigozzi F, Spataro A, Norbiato G, et al. (2002) Conversion from vagal to sympathetic predominance with strenuous training in high-performance world class athletes. Circulation 105: 2719–2724.
  34. 34. Tulppo MP, Kiviniemi AM, Hautala AJ, Kallio M, Seppanen T, et al. (2005) Physiological background of the loss of fractal heart rate dynamics. Circulation 112: 314–319.
  35. 35. Mourot L, Bouhaddi M, Gandelin E, Cappelle S, Dumoulin G, et al. (2008) Cardiovascular autonomic control during short-term thermoneutral and cool head-out immersion. Aviat Space Environ Med 79: 14–20.
  36. 36. Singh JP, Larson MG, O'Donnel CJ, Tsuji H, Evans JC, et al. (1999) Heritability of heart rate variability: the Framingham heart study. Circulation 99: 2251–2254.
  37. 37. Barantke M, Krauss T, Ortak J, Lieb W, Reppel M, et al. (2008) Effects of gender and aging on differential autonomic responses to orthostatic maneuvers. J Cardiovasc Electrophysiol 19: 1296–1303.
  38. 38. Hautala AJ, Makikallio TH, Kiviniemi A, Laukkanen RT, Nissila S, et al. (2003) Cardiovascular autonomic function correlates with the response to aerobic training in healthy sedentary subjects. Am J Physiol Heart Circ Physiol 285: 1747–1752.
  39. 39. Kleiger RE, Bigger JT, Bosner MS, Chung MK, Cook JR, et al. (1991) Stability over time of variables measuring heart rate variability in normal subjects. Am J Cardiol 68: 626–630.
  40. 40. Noritake M, Takase B, Kudoh K, Kugai N, Kurita A, et al. (1992) Diurnal change in heart rate variability in healthy and diabetic subjects. Intern Med 31: 453–456.